You are on Trendlyne India. Click here to go to United States website or make India as your default

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1496.4000 14.60 (0.99%)
NSE Apr 16, 2025 15:31 PM
Volume: 1.0M
 

logo
Cipla Ltd.
28 Jan 2025
1496.40
0.99%
buy
Neutral: Cipla Ltd.
by Motilal Oswal
Target: 1530 | Target met
Motilal Oswal
CIPLA delivered better-than-expected 3QFY25 earnings. While revenue was in line, EBITDA/adj. PAT beat our estimates, aided by a better product mix and lower R&D spending.
 
Cipla Ltd. is trading above its 100 day SMA of 1467.7
More from Cipla Ltd.
Recommended
Top five: Stocks that could outperform in upcoming results | Screener: Stocks with high durability scores, high target …
The Baseline | 16 Apr 2025, 05:53PM
Market closes higher, Yes Bank receives a Rs 244.2 crore tax demand for AY16-17
Trendlyne Marketwatch | 16 Apr 2025, 04:04PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022